Stelar Metals (ASX:SLB) has completed its maiden regional-scale soil geochemical survey at the Hill of Leaders Tungsten Project in the Northern Territory, with results expected in the coming weeks ahead of a maiden bedrock drilling program.

🧪 1,350 samples collected: The soil geochemical survey, which covered approximately 50km² of granite terrain on a 200m by 200m grid, targeted tungsten and a broader multi-element suite.
🔦 Granite-scale opportunity: Night-time UV lamping identified fluorescent mineralisation consistent with scheelite in granite surrounding historically mined high-grade quartz veins.
⛏️ Drilling next: Stelar has secured a rig for its planned 3,500m RC drilling program at Hill of Leaders, with mobilisation expected next week. The drilling will test whether tungsten mineralisation extends beyond the known veins into the surrounding granite.

“With maiden drilling kicking off next week, Stelar is advancing a high-impact exploration program at a time of historic tungsten prices and tightening global supply.” – Stephen Biggins, Stelar Metals Executive Chairman

Alchemy Resources (ASX:ALY) has commenced reverse circulation (RC) drilling at high-priority gold and copper targets across its Yellow Mountain and Overflow projects located in New South Wales.

⛏️ Drilling underway: The program includes up to 15 RC holes across Yellow Mountain and Overflow, targeting copper and gold mineralisation identified through earlier exploration activities.
🟠 Yellow Mountain targets: Drilling will follow up previous results, including 113m at 1.17% copper equivalent, while also testing two geophysical targets identified through follow-up IP surveys.
🥇 Overflow gold targets: Drilling will also target high-grade gold zones and extensions to the existing 342,000-ounce gold equivalent resource, testing priority areas within the project.
“Geologically all targets show signs of strong potential mineralisation, and we look forward to reporting results as they come to hand.” – James Wilson, Alchemy Resources Chief Executive Officer

ASX announcement ⚡ https://asx.api.cmfyapp.com/asx-research/1.0/file/2924-03134297-6A1343304&v=undefined

Trump unleashes after Fed hike 🇺🇸

How has Trump’s Fed pick backfired? Trump picked Kevin Warsh in January 2026, and it was no secret the President wanted lower rates. Warsh just raised them by a quarter point to between 3.75 and 4 per cent. His committee backed him 12 votes to nothing. Trump immediately responded, saying that US rates "should be 1%, or less”. Trump expected cuts. Democrats thought Warsh would do what Trump wanted. Both sides forgot that Warsh has been known as a monetary hawk for twenty years. A Fed chair doesn`t work for whoever appointed them. They work to a mandate. Full employment and stable prices. It’s the same in Australia. The RBA meets on the September 29, 2026, and no politician gets a vote. Trump’s learning that you can pick the chair, but you can’t pick the rate.

#trump #USA #wallstreet #finance #money

How do rising bond yields make stocks cheaper? When a guaranteed return rises, the price people will pay for an uncertain one falls. Australia`s ten-year bond yield just hit its highest level since 2011. So if you lend the government money for a decade, it pays you over 5%. It’s what the market calls the "risk-free rate".

Compare that to the dividend yield of the ASX 200, which is about 3.4 per cent. Franking credits lift it, but not by enough to close the gap. The risk-free rate isn`t just a return; it`s a hurdle. Shares, property, the loan your bank will write you. They`re all priced off the same starting line, and it`s at a 15-year high.

#money #stocks #US #fintok #wallstreet

Overwatch Technologies (ASX:OWL) has lodged its prospectus with a view to listing on the ASX, targeting growing demand for maritime intelligence, surveillance and reconnaissance. The Company combines drone-based platforms, specialist sensors and data aggregation to detect, map and track radio frequency emissions, with plans to expand its capabilities across land and sub-sea environments. Co-Founder and Managing Director Oscar Leslie joins The Stock Network`s Lel Smits to discuss progressing to an ASX listing, Overwatch`s technology, government opportunity and pathway to growth.

🔔 Preparing to debut on ASX
⚓️ Turning data into intelligence
🚢 Building the maritime intelligence network

AuKing Mining (ASX:AKN) has reported broad, high-grade rare earth element (REE) mineralisation from the maiden RC drilling program at the company’s Tundulu REE Project in southern Malawi, Africa. These outcomes, which came out of the first three holes of this drill campaign, exceeded historical drilling results.

🪨 Wide TREO intersections: 26NH005 returned 91m at 1.51% Total Rare Earth Oxide (TREO) from 40m, including 15m at 3.40% TREO from 90m. 26NH029 delivered 80m at 1.54% TREO from surface, including 11m at 4.33% TREO from 2m, while 26NH004 returned 20m at 2.06% TREO from 113m.
🔬 Strong heavy rare earth enrichment: The results also show unusually high HREE+Y proportions. AuKing says this distinctive signature differentiates Tundulu from conventional carbonatite-hosted deposits.
📈 Resource work begins: Based on the initial results, AuKing is taking formal steps towards an initial Mineral Resource Estimate for Tundulu. Diamond holes extending to depths of up to 510m have also intersected extensive carbonatite lithology, with samples being prepared for assay and further results expected over coming weeks.

“These results not only validate (and surpass) historical drilling results but identify the potential for a much larger mineralised footprint at Tundulu than was originally considered.” – Paul Williams, AuKing Mining Managing Director

What do you do if a cancer scan is lying? Aussie biotech Telix (ASX:TLX) just got FDA approval to answer that question with its drug, Pixclara. Here`s the problem it solves - after treatment, a scan can show something that looks exactly like a tumour but isn`t. Pixclara is injected, glioma cells take it up, and they light up on a different scan.

Glioma is the most common form of malignant brain tumour. Around 24,000 Americans are diagnosed with it every year. If you`ve ever waited on a scan result, you know what that uncertainty costs. In biotech, the cure gets the headlines. But the test gets to market first.

#ASX #biotech #health #money #stocks

he US military cares about this ASX stock 🚢

Why are US and Korean firms fighting over an Aussie company’s shipyard? Austal (ASX: ASB) just announced it has received a non-binding offer from Wildcat Infrastructure for its US arm. The bid values the business at up to US $1.35 billion USD. That tops last month’s bid from Korea’s Hanwha, which valued it at up to US $1.2 billion. So why the interest?

Austal’s USA business builds for the US Navy and Coast Guard, including modules for American nuclear submarines. You can`t just start a shipyard like that. Austal USA spent 25 years getting the clearances and contracts. So the value isn`t last year`s profit; it`s the access. And that gap in value is what drives a takeover war.

#war #stocks #US #trump #fintok